ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

REVIEW STUDY: MANAGEMENT OF TRIGEMINAL NEURALGIA

Hanan Obaidallah Al harbi, Ibrahim Abdulrahman Bakhsh, Mishal Abdullah Alghamdi, Mahmoud Mohammad Shawly, Mohamad Abdulrahman Bakhsh, Sami Samran Alrehaily

Trigeminal neuralgia (TN) is one-sided confusion portrayed by brief electric stun like pain. The management is confusing as numerous patients will get medical surgery after the failure of their medicinal treatment, while others require therapeutic treatment after the long-haul viability of medical surgery gradually weakens. This literature review was established to review the available medications and their safety and effect on quality of life. In conclusion, there’s still a debate regarding the treatment of TN as yet it’s challenging as individual’s reactions to various remedial alternatives may differ extensively. Just a couple of accessible treatment alternatives have affirmed viability satisfying current norms for proof-based drug. Although, novel medical alternatives are on the ascent just because substances are in clinical testing on more numbers of patients specially for this exceptionally impairing yet uncommon disease. Result’s indicators and hazard factors for medical management failure are more methodically evaluated to an increasing extent with the goal that an individual patient-guided medication choice can be made. The constant exertion by clinicians, scientists, and the pharmaceutical business may give helpful choices that are progressively specific, tolerable and increasingly proficient for subjects diagnosed with TN. Keywords: Trigeminal neuralgia (TN),management, carbamazoid, surgery

FULL TEXT